Nuvectis Pharma, Inc. — Institutional Ownership

Which tracked institutions hold NVCT, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

17
Funds holding
$29871196
Total value held
Buying
12 added/new · 5 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $18413632 1001285 +236844 +30.98%
2 State Street Corp $4564361 248198 +81682 +49.05%
3 Northern Trust Corp $2698071 146714 +22502 +18.12%
4 Ubs Group Ag $1272588 69200 +69200 NEW BUY
5 Bank Of New York Mellon Corp $676192 36770 +6455 +21.29%
6 Sei Investments Co $514240 27963 +27963 NEW BUY
7 Goldman Sachs Group Inc $376627 20480 -20644 -50.20%
8 Morgan Stanley $344279 18721 -3847 -17.05%
9 Wells Fargo & Company/Mn $286774 15594 +9975 +177.52%
10 Bank Of America Corp /De/ $218290 11870 -2977 -20.05%
11 Jpmorgan Chase & Co $202306 7091 +619 +9.56%
12 Citigroup Inc $147396 8015 +7629 +1976.42%
13 Toronto Dominion Bank $88713 4824 +4824 NEW BUY
14 Barclays Plc $56292 3061 -60 -1.92%
15 Royal Bank Of Canada $10000 535 -729 -57.67%
16 Federated Hermes, Inc. $920 50 +50 NEW BUY
17 Pnc Financial Services Group, Inc. $515 28 +5 +21.74%

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.